Differentiating Benign and Intermediate-Grade Risk Across the Spectrum of Dermal Melanocytic Proliferations

February 2026 | Vol. 70, No. 1
By Michelle Kaminski, MPH¹, Alex Silberzweig, BA², Alexander Velaoras, BS³, Haily Fritts, BS⁴, Kelly Fraiser⁵, DO, MS, Alina G. Bridges, DO, FAAD⁵

¹Lake Erie College of Osteopathic Medicine, ²Zucker School of Medicine at Hofstra/Northwell, ³Drexel University College of Medicine, ⁴Idaho College of Osteopathic Medicine, ⁵Department of Dermatology, Northwell, New Hyde Park, NY